Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Smith

Showing results (221-230 of 618) with videos related to

Pageof 62
Sort By:
Current Pharmaceutical Design|September 10, 2011
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic interventionDavid J Bonda, Mark A Smith, George Perry, et al.
Alzheimer Disease and Associated Disorders|June 9, 2005
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesisKate M Webber, Gemma Casadesus, George Perry, et al.
Biochimica Et Biophysica Acta|June 14, 2005
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's diseaseIsmael Santa-María, Mark A Smith, George Perry, et al.
Infection and Immunity|October 24, 2012
Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladderTamako A Garcia, Christy L Ventura, Mark A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studiesNanditha Nair, Wataru Kudo, Mark A Smith, et al.
Free Radical Research|April 8, 2010
Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acidMasao Nakamura, Naomi Shishido, Akihiko Nunomura, et al.
Journal of Neurochemistry|June 17, 2003
Distribution, levels, and activation of MEK1 in Alzheimer's diseaseXiongwei Zhu, Zheng Sun, Hyoung-gon Lee, et al.
Chemistry & Biology|August 28, 2012
Identification of the binding site of Brucella VirB8 interaction inhibitorsMark A Smith, Mathieu Coinçon, Athanasios Paschos, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Oxidative stress and neurodegenerationPaula I Moreira, Mark A Smith, Xiongwei Zhu, et al.
JAMA|February 3, 2005
Dementia and testosterone levels in menRichard L Bowen, Ralph N Martins, Christopher W Gregory, et al.
Pageof 62

Showing results (221-230 of 618) with videos related to

Sort By:
Pageof 62
Current Pharmaceutical Design|September 10, 2011
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic interventionDavid J Bonda, Mark A Smith, George Perry, et al.
Alzheimer Disease and Associated Disorders|June 9, 2005
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesisKate M Webber, Gemma Casadesus, George Perry, et al.
Biochimica Et Biophysica Acta|June 14, 2005
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's diseaseIsmael Santa-María, Mark A Smith, George Perry, et al.
Infection and Immunity|October 24, 2012
Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladderTamako A Garcia, Christy L Ventura, Mark A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studiesNanditha Nair, Wataru Kudo, Mark A Smith, et al.
Free Radical Research|April 8, 2010
Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acidMasao Nakamura, Naomi Shishido, Akihiko Nunomura, et al.
Journal of Neurochemistry|June 17, 2003
Distribution, levels, and activation of MEK1 in Alzheimer's diseaseXiongwei Zhu, Zheng Sun, Hyoung-gon Lee, et al.
Chemistry & Biology|August 28, 2012
Identification of the binding site of Brucella VirB8 interaction inhibitorsMark A Smith, Mathieu Coinçon, Athanasios Paschos, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Oxidative stress and neurodegenerationPaula I Moreira, Mark A Smith, Xiongwei Zhu, et al.
JAMA|February 3, 2005
Dementia and testosterone levels in menRichard L Bowen, Ralph N Martins, Christopher W Gregory, et al.
Pageof 62